Go Pro
→ The SEC Just Opened The Floodgates… (From StocksToTrade) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dogwood Therapeutics, Inc stock logo
DWTX
Dogwood Therapeutics
$1.51
+5.2%		$1.92
$1.28
▼
$7.20
$51.16M1.9376,120 shs45,052 shs
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
$2.04
$2.15
$1.79
▼
$5.18
$42.90M0.33382,141 shs58,099 shs
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
$1.78
-4.8%		$2.95
$2.90
▼
$23.42
$12.25M1.4116,506 shs1.17 million shs
RYTHM, Inc. stock logo
RYM
RYTHM
$20.03
+0.2%		$21.98
$14.00
▼
$53.65
$43.66M9.4614,849 shs14,297 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dogwood Therapeutics, Inc stock logo
DWTX
Dogwood Therapeutics
+5.93%0.00%-45.63%-4.03%-79.77%
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
-5.12%-5.56%-2.86%-13.92%-33.55%
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
+0.54%-4.10%-33.69%-53.02%-88.96%
RYTHM, Inc. stock logo
RYM
RYTHM
-4.63%-9.67%-11.66%-19.98%-51.39%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dogwood Therapeutics, Inc stock logo
DWTX
Dogwood Therapeutics
$1.51
+5.2%		$1.92
$1.28
▼
$7.20
$51.16M1.9376,120 shs45,052 shs
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
$2.04
$2.15
$1.79
▼
$5.18
$42.90M0.33382,141 shs58,099 shs
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
$1.78
-4.8%		$2.95
$2.90
▼
$23.42
$12.25M1.4116,506 shs1.17 million shs
RYTHM, Inc. stock logo
RYM
RYTHM
$20.03
+0.2%		$21.98
$14.00
▼
$53.65
$43.66M9.4614,849 shs14,297 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dogwood Therapeutics, Inc stock logo
DWTX
Dogwood Therapeutics
+5.93%0.00%-45.63%-4.03%-79.77%
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
-5.12%-5.56%-2.86%-13.92%-33.55%
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
+0.54%-4.10%-33.69%-53.02%-88.96%
RYTHM, Inc. stock logo
RYM
RYTHM
-4.63%-9.67%-11.66%-19.98%-51.39%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Dogwood Therapeutics, Inc stock logo
DWTX
Dogwood Therapeutics
2.00
Hold$12.00697.34% Upside
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
2.00
Hold$6.00194.12% Upside
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
2.33
Hold$51.752,807.30% Upside
RYTHM, Inc. stock logo
RYM
RYTHM
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest PSTV, RYM, DWTX, and GRCE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/2/2026
Dogwood Therapeutics, Inc stock logo
DWTX
Dogwood Therapeutics
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
8/13/2026
RYTHM, Inc. stock logo
RYM
RYTHM
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
8/3/2026
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
7/24/2026
Dogwood Therapeutics, Inc stock logo
DWTX
Dogwood Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/17/2026
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/17/2026
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 10/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Dogwood Therapeutics, Inc stock logo
DWTX
Dogwood Therapeutics
N/AN/AN/AN/A$2.33 per shareN/A
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
N/AN/AN/AN/A$3.99 per shareN/A
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
N/AN/AN/AN/A$0.72 per shareN/A
RYTHM, Inc. stock logo
RYM
RYTHM
$17.28M2.53N/AN/A$6.06 per share3.31
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Dogwood Therapeutics, Inc stock logo
DWTX
Dogwood Therapeutics
-$34.26M-$8.95N/AN/AN/AN/A-75.55%-40.28%11/5/2026 (Estimated)
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
-$7.79M-$1.18N/AN/AN/AN/A-36.11%-34.39%11/12/2026 (Estimated)
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
-$22.39M-$2.30N/AN/AN/A-230.24%-198.48%-73.13%N/A
RYTHM, Inc. stock logo
RYM
RYTHM
-$33.26M-$10.53N/AN/AN/A-6.20%-12.57%-2.60%N/A

Latest PSTV, RYM, DWTX, and GRCE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q1 2027
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
-$0.1293-$0.91-$0.7807-$0.91$0.40 millionN/A
8/13/2026Q2 2026
Dogwood Therapeutics, Inc stock logo
DWTX
Dogwood Therapeutics
-$0.14-$0.34-$0.20-$0.34N/AN/A
8/13/2026Q2 2026
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
-$0.88-$1.31-$0.43-$1.31$1.11 million$0.41 million
8/4/2026Q2 2026
RYTHM, Inc. stock logo
RYM
RYTHM
N/A$0.09N/A$0.09N/A$23.02 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Dogwood Therapeutics, Inc stock logo
DWTX
Dogwood Therapeutics
N/AN/AN/AN/AN/A
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
N/AN/AN/AN/AN/A
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
N/AN/AN/AN/AN/A
RYTHM, Inc. stock logo
RYM
RYTHM
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Dogwood Therapeutics, Inc stock logo
DWTX
Dogwood Therapeutics
N/A
3.89
3.89
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
N/A
11.47
11.47
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
N/A
2.27
2.27
RYTHM, Inc. stock logo
RYM
RYTHM
N/A
0.59
0.56

Institutional Ownership

CompanyInstitutional Ownership
Dogwood Therapeutics, Inc stock logo
DWTX
Dogwood Therapeutics
9.05%
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
6.08%
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
3.28%
RYTHM, Inc. stock logo
RYM
RYTHM
5.98%

Insider Ownership

CompanyInsider Ownership
Dogwood Therapeutics, Inc stock logo
DWTX
Dogwood Therapeutics
0.30%
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
10.84%
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
2.50%
RYTHM, Inc. stock logo
RYM
RYTHM
3.48%
CompanyEmployeesShares OutstandingFree FloatOptionable
Dogwood Therapeutics, Inc stock logo
DWTX
Dogwood Therapeutics
833.99 million33.89 millionN/A
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
521.04 million18.76 millionN/A
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
206.88 million6.71 millionNot Optionable
RYTHM, Inc. stock logo
RYM
RYTHM
1412.18 million2.10 millionN/A

Recent News About These Companies

Head to Head Analysis: RYTHM (RYM) and Its Peers
September 24, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31044718
RYTHM (RYM) & Its Rivals Critical Analysis
September 24, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31043052
Financial Contrast: RYTHM (NASDAQ:RYM) and Fortress Biotech (NASDAQ:FBIO)
September 21, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31035668
RYTHM Introduces Lifted Lemon, a New THC Twist on Iced Tea and Lemonade
August 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/20/3348222/0/en/rythm-introduces-lifted-lemon-a-new-thc-twist-on-iced-tea-and-lemonade.html
RYTHM Inc
August 19, 2026  |  markets.ft.comhttps://markets.ft.com/data/equities/tearsheet/summary?s=RYM:NAQ
RYTHM Shareholders Approve Dilutive Equity Issuance Changes
August 11, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/rythm-shareholders-approve-dilutive-equity-issuance-changes?utm_source=marketbeat.com&utm_medium=referral
RYTHM Swings to Earnings in Q2 on THC Beverage Growth
August 7, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2971401/rythm-swings-to-earnings-in-q2-on-thc-beverage-growth?cid=cs-stocknewsapi-ft-microcap_article|earnings-2971401
RYTHM, Inc. Reports Record Second-Quarter 2026 Revenue Growth and Strong THC Beverage Momentum
August 4, 2026  |  quiverquant.comQ
RYTHM, Inc. Reports Second Quarter 2026 Results
August 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/04/3338135/0/en/rythm-inc-reports-second-quarter-2026-results.html
RYTHM (NASDAQ:RYM) Trading Up 14% – Time to Buy?
August 4, 2026  |  defenseworld.netD
RYTHM, Inc. (RYM) Stock Major Holders - Yahoo Finance
July 27, 2026  |  ca.finance.yahoo.comhttps://ca.finance.yahoo.com/quote/RYM/holders/
Señorita Brings THC Beverages to Lollapalooza for the First Time
July 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/23/3332009/0/en/se%c3%b1orita-brings-thc-beverages-to-lollapalooza-for-the-first-time.html
Rythm Stock Short Interest Report | NASDAQ:RYM | Benzinga
July 17, 2026  |  benzinga.comhttps://www.benzinga.com/quote/RYM/short-interest
RYTHM (NASDAQ:RYM) Director Sells 2,250 Shares
June 19, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-rym-insider-buying-and-selling-2026-06-19/
RYTHM Inc.
May 16, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/rym/financials/cash-flow
Señorita Named Official THC Beverage Partner of Opry Entertainment Group Venues
May 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/14/3294752/0/en/se%c3%b1orita-named-official-thc-beverage-partner-of-opry-entertainment-group-venues.html
Rythm Inc Ordinary Shares RYM
May 13, 2026  |  morningstar.comM
RYTHM Stock Price History
May 12, 2026  |  investing.comhttps://www.investing.com/equities/agrify-corp-historical-data
RYTHM's Q1 Earnings Rise Y/Y on Licensing Agreement Benefits
May 11, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2919257/rythm-s-q1-earnings-rise-y-y-on-licensing-agreement-benefits?cid=cs-stocknewsapi-ft-microcap_article|earnings-2919257
Navy Pier Names RYTHM as Its Official THC Beverage Partner
May 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/08/3291219/0/en/navy-pier-names-rythm-as-its-official-thc-beverage-partner.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Dogwood Therapeutics stock logo

Dogwood Therapeutics NASDAQ:DWTX

$1.50 +0.08 (+5.24%)
As of 02:57 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

Grace Therapeutics stock logo

Grace Therapeutics NASDAQ:GRCE

$2.04 0.00 (0.00%)
As of 02:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Grace Therapeutics Inc. is a late-stage biopharma company advancing GTx-104, its novel injectable formulation of nimodipine which addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage. Grace Therapeutics Inc., formerly known as Acasti Pharma Inc., is based in Princeton, New Jersey.

Plus Therapeutics stock logo

Plus Therapeutics NASDAQ:PSTV

$1.78 -0.09 (-4.81%)
As of 10/1/2026

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. Its lead radiotherapeutic drug candidate is rhenium (186Re) obisbemeda, a patented radiotherapy that targets central nervous system cancers and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.

RYTHM stock logo

RYTHM NASDAQ:RYM

$20.03 +0.03 (+0.15%)
As of 02:56 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Billerica, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas